World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
14871
World Ranking
2852
National Ranking
1348

Elena A. Govorkova publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elena A. Govorkova sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 158 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elena A. Govorkova D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elena A. Govorkova sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Elena A. Govorkova is affiliated with St. Jude Children's Research Hospital in the United States. Their research primarily focuses on influenza virus studies within the field of medicine, contributing extensively to epidemiology, infectious diseases, and immunology.

The scientist's main areas of study include:

  • Medicine
  • Epidemiology
  • Infectious Diseases
  • Immunology
  • Materials Chemistry
  • Agronomy and Crop Science

The key research topics covered in their work are:

  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Animal Disease Management and Epidemiology
  • Interferon and immune responses
  • Viral Infections and Immunology Research
  • Viral Infections and Vectors

Govorkova has published extensively in several notable scientific venues. Frequent publication venues include:

  • Antiviral Research
  • Nature Communications
  • The Cambridge Structural Database
  • PLoS Pathogens
  • Journal of Antimicrobial Chemotherapy

Their recent scholarly articles include:

  • "Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America," 2023, Nature Communications
  • "Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020," 2022, Antiviral Research
  • "Influenza antivirals and their role in pandemic preparedness," 2022, Antiviral Research
  • "Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility," 2020, Proceedings of the National Academy of Sciences
  • "Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida," 2024, Communications Biology

The scientist collaborates regularly with several co-authors, including:

  • Jeremy C. Jones
  • Richard J. Webby
  • Philippe Noriel Q. Pascua
  • Ahmed Kandeil
  • Thomas Fabrizio

Best Publications

  • Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia

    D. J. Hulse-Post;K. M. Sturm-Ramirez;J. Humberd;P. Seiler

  • Are Ducks Contributing to the Endemicity of Highly Pathogenic H5N1 Influenza Virus in Asia

    K. M. Sturm-Ramirez;D. J. Hulse-Post;E. A. Govorkova;J. Humberd

  • H5N1 Influenza — Continuing Evolution and Spread

    Robert G Webster;Elena A Govorkova

  • T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses in Vitro

    Tatiana Baranovich;Sook-San Wong;Jianling Armstrong;Henju Marjuki

  • Lethality to Ferrets of H5N1 Influenza Viruses Isolated from Humans and Poultry in 2004

    Elena A. Govorkova;Jerold E. Rehg;Scott Krauss;Hui-Ling Yen

  • Continuing challenges in influenza

    Robert G. Webster;Elena A. Govorkova

  • The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04

    Rachelle Salomon;John Franks;Elena A. Govorkova;Natalia A. Ilyushina

  • Evolution of H5N1 avian influenza viruses in Asia

    Jean Thierry Aubin;Saliha Azebi;Amanda Balish;Jill Banks

  • Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses

    Elena A. Govorkova;Irina A. Leneva;Olga G. Goloubeva;Karen Bush

  • Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

    RJ Webby;Perez;JS Coleman;Y Guan

  • Influenza: Emergence and Control

    Aleksandr S. Lipatov;Elena A. Govorkova;Richard J. Webby;Hiroichi Ozaki

  • Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility

    Hui-Ling Yen;Hui-Ling Yen;Louise M. Herlocher;Erich Hoffmann;Mikhail N. Matrosovich

  • Characterization of H5N1 Influenza Viruses That Continue To Circulate in Geese in Southeastern China

    Robert G. Webster;Yi Guan;Malik Peiris;David Walker

  • Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.

    Nikolai V. Kaverin;Irina A. Rudneva;Natalia A. Ilyushina;Natalia L. Varich

  • The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

    Irina A. Leneva;Noel Roberts;Elena A. Govorkova;Olga G. Goloubeva

  • Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies

    Nikolai V. Kaverin;Irina A. Rudneva;Elena A. Govorkova;Tatyana A. Timofeeva

  • Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

    Hui-Ling Yen;Hui-Ling Yen;Arnold S. Monto;Robert G. Webster;Robert G. Webster;Elena A. Govorkova

  • Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America

    Unknown

  • Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses

    Hui-Ling Yen;Erich Hoffmann;Garry Taylor;Christoph Scholtissek

  • African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

    E A Govorkova;G Murti;B Meignier;C de Taisne

  • Immunization with Reverse-Genetics–Produced H5N1 Influenza Vaccine Protects Ferrets against Homologous and Heterologous Challenge

    Elena A. Govorkova;Richard J. Webby;Jennifer Humberd;Jon P. Seiler

  • Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo

    Hui-Ling Yen;Natalia A. Ilyushina;Rachelle Salomon;Erich Hoffmann

Frequent Co-Authors

Robert G. Webster
Robert G. Webster St. Jude Children's Research Hospital
Richard J. Webby
Richard J. Webby St. Jude Children's Research Hospital
Yi Guan
Yi Guan University of Hong Kong
Scott Krauss
Scott Krauss St. Jude Children's Research Hospital
Charles J. Russell
Charles J. Russell St. Jude Children's Research Hospital
Hui-Ling Yen
Hui-Ling Yen University of Hong Kong
Peter Vogel
Peter Vogel St. Jude Children's Research Hospital
Stacey Schultz-Cherry
Stacey Schultz-Cherry St. Jude Children's Research Hospital
Malik Peiris
Malik Peiris University of Hong Kong
Young Ki Choi
Young Ki Choi Institute for Basic Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Nursing roles, particularly advanced practice degrees, complement immunology expertise by focusing on patient care and disease prevention. Prospective students might consider programs listed under easiest nurse practitioner degree programs to find options balancing rigor with accessibility.

Specializations such as Psychiatric Mental Health Nurse Practitioner (PMHNP) offer a unique intersection between immunological factors and mental health. Many online PMHNP programs boast impressive clinical experiences, as highlighted in the article on online pmhnp programs with clinical placement, which ensures students gain vital hands-on skills.

Affordability remains a critical consideration for students. Programs identified among the affordable pmhnp programs allow learners to pursue advanced degrees while managing costs effectively.

Career outcomes and salary expectations are equally important. Transparency in compensation, such as insights provided by the dnp salary transparency resource, helps graduates plan for their financial futures after earning a Doctor of Nursing Practice degree.

Best Scientists Citing Elena A. Govorkova

Trending Scientists

Recently Published Articles